(Q40540390)

21 September 2017

Death induction by recombinant native TRAIL and its prevention by a caspase 9 inhibitor in primary human esophageal epithelial cells (English)

1 reference

21 September 2017

5

Meenhard Herlyn

1 reference

21 September 2017

Seok-Hyun Kim

1

1 reference

21 September 2017

Kunhong Kim

2

1 reference

21 September 2017

Jae G Kwagh

3

1 reference

21 September 2017

David T Dicker

4

1 reference

21 September 2017

Anil K Rustgi

6

1 reference

21 September 2017

Youhai Chen

7

1 reference

21 September 2017

Wafik S El-Deiry

8

1 reference

21 September 2017

language of work or name

English

0 references

publication date

28 June 2004

1 reference

Journal of Biological Chemistry

21 September 2017

1 reference

21 September 2017

279

1 reference

21 September 2017

40044-40052

1 reference

21 September 2017

38

1 reference

The receptor for the cytotoxic ligand TRAIL

21 September 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404541200

TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404541200

KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404541200

An antagonist decoy receptor and a death domain-containing receptor for TRAIL

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404541200

Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404541200

TRUNDD, a new member of the TRAIL receptor family that antagonizes TRAIL signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404541200

Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404541200

Caspases - controlling intracellular signals by protease zymogen activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404541200

Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404541200

Mitochondria and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404541200

Tumor necrosis factor receptor and Fas signaling mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404541200

FLICE is activated by association with the CD95 death-inducing signaling complex (DISC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404541200

An induced proximity model for caspase-8 activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404541200

Identification and characterization of a new member of the TNF family that induces apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404541200

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404541200

Safety and antitumor activity of recombinant soluble Apo2 ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404541200

An inducible pathway for degradation of FLIP protein sensitizes tumor cells to TRAIL-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404541200

Epidermal growth factor receptor mediates increased cell proliferation, migration, and aggregation in esophageal keratinocytes in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404541200

Human melanoma progression in skin reconstructs : biological significance of bFGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404541200

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404541200

Identification of inhibitors of TRAIL-induced death (ITIDs) in the TRAIL-sensitive colon carcinoma cell line SW480 using a genetic approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404541200

Requirement of p53 targets in chemosensitization of colonic carcinoma to death ligand therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404541200

Pathways involved in proliferating, senescent and immortalized keratinocyte cell death mediated by two different TRAIL preparations

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404541200

A unique zinc-binding site revealed by a high-resolution X-ray structure of homotrimeric Apo2L/TRAIL

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404541200

Molecular ordering of the initial signaling events of CD95.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404541200

Two CD95 tumor classes with different sensitivities to antitumor drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404541200

21 January 2018

Identifiers

DOI

10.1074/JBC.M404541200

1 reference

21 September 2017

1 reference